NIH Clinical Trial of investigational vaccine for Covid-19 begins


17-03-2020
Study enrolling Seattle-based healthy adult volunteers. The study is evaluating different doses of the experimental vaccine for safety and its ability to induce an immune response in participants.
 
A Phase 1 clinical trial evaluating an investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) has begun at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle. The National Institute of Allergy and Infectious Diseases (NIAID) , part of the National Institutes of Health, is funding the trial. ...